Table 4 Results of logistic regression analysis

Age

1.05 (1.05–1.06)***

Male

0.64 (0.52–0.78)***

VB1_2

0.53 (0.26–1.08)

VB1_3

0.22 (0.04–1.14)

VB12_2

0.48 (0.23–1.03)

VB12_3

0.45 (0.18–1.12)

Folate_2

0.75 (0.42–1.34)

Free T3_2

1.47 (0.86–2.52)

Free T3_3

2.14 (0.90–5.12)

BNP_3

0.68 (0.47–1.00)

Free T4_2

0.38 (0.09–1.61)

Free T4_3

0.48 (0.09–2.60)

Carbazochrome sodium sulfonate hydrate

0.66 (0.40–1.08)

Tipepidine hibenzate

0.91 (0.44–1.90)

Aniracetam

18.27 (12.29–27.15)***

Glucose solution

0.55 (0.37–0.83)**

Glycerin

0.91 (0.50–1.67)

Saline

0.71 (0.49–1.04)

Quetiapine fumarate

2.1 (1.17–3.77)*

Glycyrrhizic acid

0.61 (0.40–0.92)*

Tranexamic acid

0.92 (0.53–1.58)

Senile dementia

11.65 (6.88–19.73)***

Dementia

5.80 (3.93–8.56)***

Cerebral infarction sequelae

1.77 (1.16–2.71)**

Neurosis

3.27 (2.35–4.55)***

Schizophrenia

2.82 (1.96–4.07)***

Sleep disturbance

0.79 (0.55–1.14)

Depression

1.81 (1.30–2.53)***

Cerebral infarction

1.63 (1.24–2.15)***

Cerebral arteriosclerosis

0.88 (0.46–1.68)

Cerebrovascular accident

1.63 (1.14–2.34)**

Heart failure

2.18 (1.57–3.02)***

Hypercholesterolemia

1.81 (1.16–2.82)**

Hypothyroidism

2.98 (2.20–4.04)***

Angina pectoris

1.15 (0.79–1.68)

Common cold

0.53 (0.31–0.91)*